Free Trial

PharmaCyte Biotech (PMCB) Short Interest Ratio & Short Volume

$2.13
+0.04 (+1.91%)
(As of 02:32 PM ET)

PharmaCyte Biotech Short Interest Data

Current Short Interest
13,000 shares
Previous Short Interest
18,200 shares
Change Vs. Previous Month
-28.57%
Dollar Volume Sold Short
$27,560.00
Short Interest Ratio
0.5 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
8,450,000 shares
Float Size
7,610,000 shares
Short Percent of Float
0.17%
Today's Trading Volume
4,818 shares
Average Trading Volume
20,790 shares
Today's Volume Vs. Average
23%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling PharmaCyte Biotech ?

Sign up to receive the latest short interest report for PharmaCyte Biotech and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PMCB Short Interest Over Time

PMCB Days to Cover Over Time

PMCB Percentage of Float Shorted Over Time

PharmaCyte Biotech Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202413,000 shares $27,560.00 -28.6%0.2%0.5 $2.12
4/15/202418,200 shares $38,402.00 -60.2%0.2%0.7 $2.11
3/31/202445,700 shares $108,309.00 +501.3%0.6%1.8 $2.37
3/15/20247,600 shares $14,820.00 -68.7%0.1%0.3 $1.95
2/29/202424,300 shares $51,030.00 -4.3%0.3%1.6 $2.10
2/15/202425,400 shares $53,086.00 -19.4%0.4%1.6 $2.09
1/31/202431,500 shares $68,985.00 +18.9%0.4%2 $2.19
1/15/202426,500 shares $59,625.00 -14.8%0.4%1.5 $2.25
12/31/202331,100 shares $67,176.00 +15.2%0.5%1.8 $2.16
12/15/202327,000 shares $58,050.00 +2.7%0.4%1.5 $2.15
11/30/202326,300 shares $59,438.00 -9.6%0.4%1.4 $2.26
11/15/202329,100 shares $59,364.00 -12.6%0.4%1.5 $2.04
10/31/202333,300 shares $70,596.00 -17.4%0.5%1.6 $2.12
10/15/202340,300 shares $84,227.00 -12.2%0.6%1.9 $2.09
9/30/202345,900 shares $96,390.00 -27.8%0.7%2.1 $2.10
9/15/202363,600 shares $159,000.00 +27.0%0.9%3 $2.50
8/31/202350,100 shares $122,745.00 -4.0%0.6%1.9 $2.45
6/30/202139,300 shares $424.44 +48.9%N/A0 $0.01
6/15/202126,400 shares $298.32 -27.7%N/A0 $0.01
5/28/202136,500 shares $463.55 -69.0%N/A0 $0.01
5/14/2021117,600 shares $1,481.76 +113.4%N/A0 $0.01
4/30/202155,100 shares $936.70 -72.2%N/A0 $0.02
4/15/2021198,000 shares $3,245.22 +11.1%N/A0 $0.02
3/31/2021178,200 shares $3,073.95 +11.0%N/A0 $0.02
3/15/2021160,500 shares $3,370.50 +817.1%N/A0 $0.02
2/26/202117,500 shares $507.50 -93.3%N/A0 $0.03
2/12/2021260,800 shares $4,824.80 +327.5%N/A0 $0.02
1/29/202161,000 shares $1,037.00 +42.9%N/A0 $0.02
1/15/202128,200 shares $383.52 -69.7%N/A0 $0.01
12/31/202041,700 shares $271.05 +47.9%N/A0 $0.01
12/15/202028,200 shares $155.10 -69.7%N/A0 $0.01
11/30/202093,200 shares $559.20 +486.2%N/A0 $0.01
11/15/202015,900 shares $108.12 No ChangeN/A0 $0.01
10/30/202015,900 shares $141.51 +13.6%N/A0 $0.01
10/15/202014,000 shares $131.60 -74.0%N/A0 $0.01
9/30/202053,900 shares $916.30 +20.0%N/A0 $0.02
9/15/202044,900 shares $493.90 -58.9%N/A0 $0.01
8/31/2020109,300 shares $1,300.67 +680.7%N/A0 $0.01
8/14/202014,000 shares $196.00 -95.6%N/A0 $0.01
7/31/2020319,600 shares $4,474.40 +413.0%N/A0 $0.01
$1,500 to $9,400 in one month? (A.I. Trade List) (Ad)

This brand new A.I. Machine finds stocks and options trades which have had nearly PERFECT WIN RATES and gains as high as 1729%*

Click here to reserve your free seat
7/15/202062,300 shares $1,264.69 -77.0%N/A0 $0.02
6/30/2020270,500 shares $6,951.85 +69.3%N/A0 $0.03
6/15/2020159,800 shares $4,634.20 +1,041.4%N/A0 $0.03
5/29/202014,000 shares $270.20 -94.9%N/A0 $0.02
5/15/2020276,100 shares $5,936.15 +434.0%N/A0 $0.02
4/30/202051,700 shares $1,266.65 +1.0%N/A0 $0.02
4/15/202051,200 shares $1,459.20 +92.5%N/A0 $0.03
3/31/202026,600 shares $798.00 +68.4%N/A0 $0.03
3/13/202015,800 shares $624.10 -78.2%N/A0 $0.04
2/28/202072,300 shares $2,169.00 -58.1%N/A0 $0.03
2/14/2020172,600 shares $8,630.00 +245.9%N/A0 $0.05
1/31/202049,900 shares $2,495.00 -77.7%N/A0 $0.05
1/15/2020224,000 shares $11,244.80 +215.5%N/A0 $0.05
12/31/201971,000 shares $3,550.00 -54.3%N/A0 $0.05

PMCB Short Interest - Frequently Asked Questions

What is PharmaCyte Biotech's current short interest?

Short interest is the volume of PharmaCyte Biotech shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 13,000 shares of PMCB short. 0.17% of PharmaCyte Biotech's shares are currently sold short. Learn More on PharmaCyte Biotech's current short interest.

What is a good short interest percentage for PharmaCyte Biotech?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.17% of PharmaCyte Biotech's floating shares are currently sold short.

Is PharmaCyte Biotech's short interest increasing or decreasing?

PharmaCyte Biotech saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 13,000 shares, a drop of 28.6% from the previous total of 18,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is PharmaCyte Biotech's float size?

PharmaCyte Biotech currently has issued a total of 8,450,000 shares. Some of PharmaCyte Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. PharmaCyte Biotech currently has a public float of 7,610,000 shares.

How does PharmaCyte Biotech's short interest compare to its competitors?

0.17% of PharmaCyte Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to PharmaCyte Biotech: Senti Biosciences, Inc. (1.05%), Aptose Biosciences Inc. (0.86%), Evaxion Biotech A/S (0.98%), Coeptis Therapeutics Holdings, Inc. (0.57%), BioCardia, Inc. (0.96%), Genetic Technologies Limited (0.58%), Organovo Holdings, Inc. (4.09%), Scinai Immunotherapeutics Ltd. (0.47%), Creative Medical Technology Holdings, Inc. (1.55%), Titan Pharmaceuticals, Inc. (1.99%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short PharmaCyte Biotech stock?

Short selling PMCB is an investing strategy that aims to generate trading profit from PharmaCyte Biotech as its price is falling. PMCB shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against PharmaCyte Biotech?

A short squeeze for PharmaCyte Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PMCB, which in turn drives the price of the stock up even further.

How often is PharmaCyte Biotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PMCB, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:PMCB) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners